Researchers uncover mechanism fueling prostate cancer

As­traZeneca said on Mon­day morn­ing it is build­ing a new an­ti­body-drug con­ju­gate fa­cil­i­ty in Sin­ga­pore worth $1.5 bil­lion. The UK phar­ma said this will be

Ko­re­an biosim­i­lar mak­er Cell­tri­on will be con­struct­ing a new man­u­fac­tur­ing fa­cil­i­ty in South Ko­rea. A re­port from Ko­rea Bio­med­ical Re­view on Tues­day said that Cell­tri­on

As the president-elect of the American Medical Association (AMA), Bobby Mukkamala (pronounced “moo-COM-ala”), MD, an otolaryngologist in Flint, Michigan, will be working on the association’s